Introduction: the oxidative stress (OS) has been recognized as a co-factor of HIV infection evolution to AIDS condition.
Objectives: to evaluate the possible antioxidant effect and the impact on the functioning of several systems in the body, resulting in the toxicological safety of Vimang use.
Methods: sixty eight HIV-seropositive patients were double-blind randomized in two groups; the first was supplied with Vimang during six months and the other with placebo.